Survey of methicillin-resistant Staphylococcus aureus from neonates and the environment in the NICU

Shigeru Fujimura1, Seiichi Kato, Motoya Hashimoto

  • 1Department of Microbiology, Miyagi University, 1 Gakuen, Taiwa-cho, Miyagi 981-3298, Japan. hujimura@myu.ac.jp

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) is a growing concern in Japanese neonatal intensive care units (NICUs). This study found persistent MRSA strains in NICU patients and environments, highlighting the need for environmental controls to prevent nosocomial infections.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Hospital Epidemiology

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant risk for nosocomial infections in vulnerable populations, particularly neonates.
  • Increasing prevalence of MRSA carriage among children in Japan necessitates investigation into healthcare-associated MRSA transmission.
  • Previous reports indicate MRSA-related nosocomial infections in pediatric and neonatal intensive care units (NICUs).

Purpose of the Study:

  • To investigate the prevalence and genetic types of MRSA strains isolated from neonates and their NICU environments.
  • To determine the persistence of specific MRSA genotypes within the NICU setting over a 6-month period.
  • To assess the potential for MRSA transmission between neonates and their immediate surroundings.

Main Methods:

  • Collection of 37 MRSA strains from neonates and 52 strains from NICU environments over 6 months (January-June 2001).
  • DNA typing of isolated MRSA strains using arbitrary primed-PCR (AP-PCR) to classify genotypes.
  • Analysis of MRSA strain distribution and persistence in both clinical and environmental samples.

Main Results:

  • Thirty-seven clinical MRSA isolates were classified into four main types (A, B, C, D) and others.
  • A specific MRSA genotype (A type) was persistently isolated from patients for over 6 months.
  • The A-type MRSA was detected in 23.1% of environmental samples and frequently found in patient vicinity areas.

Conclusions:

  • The A-type MRSA genotype demonstrated significant persistence in the NICU, suggesting a potential source of nosocomial infection.
  • While severe MRSA infections were not observed in the neonates, the continuous isolation of the same genotype from patients and the environment underscores transmission risks.
  • Implementing stringent environmental controls within NICUs is crucial for preventing MRSA acquisition and nosocomial infections in neonates.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...